1 January 2010 Real-time, closed-loop dual-wavelength optical polarimetry for glucose monitoring
Author Affiliations +
J. of Biomedical Optics, 15(1), 017002 (2010). doi:10.1117/1.3290819
The development of a real-time, dual-wavelength optical polarimetric system to ultimately probe the aqueous humor glucose concentrations as a means of noninvasive diabetic glucose monitoring is the long-term goal of this research. The key impact of the work is the development of an approach for the reduction of the time-variant corneal birefringence due to motion artifact, which is still a limiting factor preventing the realization of such a device. Our dual-wavelength approach utilizes real-time, closed-loop feedback that employs a classical three-term feedback controller and efficiently reduces the effect of motion artifact that appears as a common noise source for both wavelengths. In vitro results are shown for the open-loop system, and although the dual-wavelength system helps to reduce the noise, it is shown that closed-loop control is necessary to bring the noise down to a sufficient level for physiological monitoring. Specifically, in vitro measurement results with the closed-loop dual-wavelength approach demonstrate a sensitivity of 12.8 mg/dl across the physiologic glucose range in the presence of time-variant test cell birefringence. Overall, it is shown that this polarimetric system has the potential to be used as a noninvasive measure of glucose for diabetes.
Malik and Coté: Real-time, closed-loop dual-wavelength optical polarimetry for glucose monitoring



Intensive treatment of diabetes and its related complications includes maintenance of near-normal blood glucose levels, which requires frequent use of glucose sensing devices.1 Currently, most commercially available glucose monitors are invasive, requiring a finger or forearm stick, which may adversely affect disease control due to difficulty and pain associated with such devices. A noninvasive glucose sensor can, therefore, become an important component of the management of diabetes and serve as a tool to guide further treatment. Development of such devices includes sensors based on optical transducers that employ light to detect glucose molecules, usually in a concentration-dependent manner. Several optical modalities have been employed as means to ascertain glucose levels noninvasively.2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 These include, but are not limited to, optical coherence tomography (OCT),2, 3, 4 optical polarimetry,5, 6, 7, 8, 9, 10, 11, 12 and spectroscopic techniques such as Raman,13, 14 mid-infrared (MIR),15 near-infrared (NIR),16, 17 and fluorescence spectroscopy.18, 19, 20, 21

The focus in this paper is in addressing the critical issue of corneal birefringence in the presence of eye motion for glucose monitoring using optical polarimetry. By way of background, monitoring glucose using polarimetry is based on the phenomenon of optical activity, which is the rotation of the plane of linearly polarized light passing through a solution of chiral molecules. The equation describing such interaction of light with an optically active compound is given by:


where [α] is the specific rotation at a given wavelength (λ) , α is the observed rotation, C is the concentration of the optically active sample, and L is the sample path length.

One challenge for this approach is that the optical rotation associated with typical physiological glucose concentrations is on the order of a few millidegrees, which is significantly smaller than the current detection limit for turbid samples, particularly in the presence of other varying confounders such as proteins found in blood and turbid tissues.22 Hence, it is difficult to use optical polarimetry to ascertain blood glucose concentration through skin due to high depolarization of light and changes with other stronger optically active components. For this reason, the anterior chamber of the eye has been probed as a potential sensing site for polarimetric quantification of glucose.6, 12 Light absorption and scattering in the eye is very low compared to that in skin, there are virtually no large proteins in the aqueous humor, the primary optical rotatory component in the aqueous humor is glucose, and a direct correlation exists between the glucose concentration in the blood and that in the aqueous humor.11, 23

The polarimetric approaches used for glucose sensing can be divided into two classes: those that measure the change in amplitude, and those that detect the phase changes in polarization due to the chiral sample. Rabinovitch were the first to apply optical polarimetry to the aqueous humor of the eye in order to determine blood glucose concentration.5 Their design was based on an optical feedback system which utilized two Faraday rotators for feedback and compensation. Coté then developed a scheme based on true phase measurement, demonstrating the potential for millidegree sensitivity in glucose-doped water solutions.7 Their system employed a rotating linear polarizer as a modulator and a fixed linear polarizer as an analyzer. Goetz investigated a polarimetric system that used an integrator as the feedback element, and they were able to measure incremental rotation in a precision rotational mount with microdegree sensitivity.8 King reported a multispectral polarimetric system in order to account for other optically active components in the aqueous humor, which was based on modulation and compensation via a Pockels cell.9 Cameron and Coté reported a system similar to Rabinovitch, with a digital closed-loop controller that significantly enhanced the stability and repeatability of the system.10 Chou investigated an amplitude-based optical heterodyne approach that employed a Zeeman laser.11 In a subsequent work by Coté, a dual-wavelength system was utilized to minimize the effect of optical confounders in aqueous humor, and potentially, corneal birefringence coupled with motion artifact.24 They were also able to investigate the glucose transport time delay between blood and aqueous humor of the eye. The average transport time lag was measured to be less than 5min .23 Ansari proposed a polarimetric system that exploited the Brewster’s reflection of circularly polarized light off of intraocular lens and were able to demonstrate its application on an eye model in vitro.25 Rawer described another Brewster’s angle–based approach that employed modulation of linearly polarized light in an open-loop system.26 More recently, Cameron and Anumula reported on development of a real-time polarimetric glucose sensor that utilized a dedicated birefringence compensator in order to account for corneal birefringence.27

While many of these techniques have shown submillidegree sensitivity and repeatability in vitro, it has been difficult to get robust results in vivo. This lack of robustness has been mainly a result of the time varying birefringence of cornea due to motion artifact. Wan proposed a dual-wavelength polarimetric approach to minimize the effect of time varying birefringence due to motion artifact and demonstrated proof of concept for using dual wavelengths to overcome birefringence.28 However, the system designed did not allow for real-time feedback and thus would not be adequate for in vivo studies. In this paper, we describe the development of a dual-wavelength optical polarimeter utilizing real-time, closed-loop feedback control to ultimately overcome corneal birefringence. We also compare the performance of our system against a dual-wavelength open-loop system.


Materials and Methods


Dual-Wavelength Optical Polarimeter

The optical configuration of our dual-wavelength system is based on a set of crossed polarizers, a modulating Faraday rotator, and dual Faraday compensators used for closing the loop. As depicted in Fig. 1 , the optical sources are two laser diode modules (Power Technology, Inc., Little Rock, Arkansas) at wavelengths of 635nm and 830nm emitting at 7mW and 20mW , respectively. The output light is polarized (1:100,000) by employing Glan-Thompson linear polarizers (Newport, Irvine, California). Each of these beams is then passed through a zero-order quarter-wave plate (Thorlabs, Newton, New Jersey) with the fast axis aligned to the incident polarization, and then another linear polarizer with transmission axis at 45deg with respect to the quarter-wave plate’s fast axis. It has been shown that this combination of a quarter-wave plate and a linear polarizer reduces the noise due to inherent fluctuations in laser polarization.29 Both the beams then pass through respective in-house-built Faraday rotators that act as rotation compensators and are present only for closed-loop operation. These compensators consist of 1-cm -long terbium-gallium-garnet (TGG) crystals (Deltronic Crystals, Inc., Dover, New Jersey) inside electrical coils. TGG crystals were employed because they are one of the highest Verdet-constant magneto-optic materials commercially available and the optical losses involved therein are lower than that of other high Verdet-constant materials. The two beams are then made coincident using a beamsplitter/combiner (Optosigma Corp., Santa Ana, California). The polarization vector is modulated using a modulating Faraday rotator at 1.09kHz with modulation depth of ±1deg . A low-power audio amplifier is utilized to provide the modulation signal to the Faraday coil, which is connected in serial to a 0.1μF capacitor in order to achieve resonance at the modulation frequency. The light then passes through a moving birefringent sample—specifically, a moving plastic cuvette with glucose-doped water solutions in the physiological range of 0to600mgdl . The moving cuvette mimics the corneal birefringence coupled with motion artifact. The input facet of the cuvette is placed perpendicular to the laser beam to maximize the amount of transmitted light. The motion of the sample is controlled using a computer-programmable translation stage (Thorlabs). The sample cuvette is moved back and forth by 400μm with a velocity of 3mms . Following the sample is another linear polarizer, which is oriented perpendicular to the initial polarizers and acts as an analyzer. The two beams are then separated using a combination of beamsplitter and bandpass filters at individual wavelengths ( 635nm and 830nm ). The detection is provided by two photodiodes (Thorlabs), followed by respective wide-bandwidth amplifiers (Melles-Griot, Albuquerque, New Mexico). Phase-sensitive detection is provided by two lock-in amplifiers (Stanford Research Systems, Sunnyvale, California), both operating at a time constant of 100ms , and the outputs of which are updated at 512Hz . For the open-loop system, these signals extracted at 1.09-kHz frequency are directly proportional to the glucose concentration of the sample. For closed-loop operation, these signals serve as inputs to a digital controller programmed in LabView 8.5 (National Instruments, Austin, Texas). The controller is essentially a proportional-integral-derivative (PID) controller providing real-time, closed-loop feedback. The output of the PID controller is connected to the respective Faraday compensators via a driver circuit.

Fig. 1

Experimental setup of the real-time dual-wavelength optical polarimetry system. The closed-loop system is distinguished from the open-loop system by the addition of the components within the dashed box. P, polarizer; λ4 , quarter-wave plate; FC, Faraday compensator; DC, driver circuit; M, mirror; BS, beamsplitter; S, sample; F, filter; D, detector; LIA, lock-in amplifier; PC, personal computer.




The operation of this system is described by the following equation:30


where I is the intensity of the detected signal, θm is the angular modulation depth provided by the modulating Faraday rotator, ωm is the modulation frequency (2π×1.09kHz) , and φ is the rotation due to the optically active sample. It follows from Eq. 2 that without an optically active sample and with the DC term removed, the detected signal consists only of the double-frequency (2ω) term. When the optically active sample is introduced, the detected signal becomes an asymmetric sinusoid, which contains both the fundamental (ω) and the double-frequency components.

In the case of a glucose sample with no birefringence, the φ term represents rotation only due to glucose, and hence the glucose concentration can be measured directly by the feedback provided to close the system loop. However, in the case of a birefringent sample, the φ term includes both optical activity and rotation due to birefringence. This makes the extraction of change due to glucose in the presence of birefringence impossible by using a single-wavelength approach, unless some type of birefringence compensation is utilized. To overcome this problem, our system utilizes two separate wavelengths in order to compensate for the effect of birefringence that is observed for both the wavelengths.


Control System

In the past, we have utilized a combination of simple proportional control and linear scanning for closed-loop polarimetry,31 whereby the output of the control system is the input multiplied by a user-defined calibration factor and then a small range of voltages were scanned to ultimately null the system. Although effective for a slower moving birefringence, the dynamic response of such a system would not be adequate for in vivo studies. Here, we compare the performance of a closed-loop system with an open-loop system using dual wavelengths. In the case of the open-loop system, the total gain of the system is fixed and is dependent mainly on the system electronics. Also, due to the open-loop nature of this process, the output is not observable by the system, and hence the system is incapable of rejecting any disturbances. For the closed-loop case, we have utilized a PID control mechanism to stabilize our feedback system and to provide optimal dynamic response. Although the use of proportional feedback control can reduce the error due to disturbances in the system, a constant input can still result in nonzero steady-state error. A common way of eliminating such error is to add a controller term proportional to the integral of the error. This virtually eliminates this error, since the integral term is the sum of all past values of the error. In our current polarimetric system, the disturbance originates due to variation in birefringence of the sample. Inclusion of an integrator usually deteriorates the dynamic response of the system. This is overcome by addition of a differentiator to the control system, which significantly improves the dynamic response. The PID gain parameters were optimized using Ziegler-Nichols tuning rules.32 In this method, the conditions for adjusting the PID parameters are based on estimating the amplitude and frequency of oscillations of the system at the point of marginal stability. In general, the controller settings according to Ziegler-Nichols rules provide acceptable closed-loop response for most systems. The optimal PID tuning parameters—i.e., proportional gain (Kp) , integral time (Ti) , and derivative time (Td) —were calculated to be 4.687, 0.00272min , and 0.000679min for 635nm and 5.677, 0.00258min , and 0.000645min for 830nm , respectively. Nevertheless, the final tuning is manual and has to be done iteratively. For our system, the only parameter that needed to be tuned manually was the Kp of the controller corresponding to 635-nm wavelength loop. The calculated Kp had to be reduced by approximately 10% to eliminate small oscillations in the transient response of the controller.


Results and Discussion

For open-loop operation, the system was first calibrated without motion using simple least-squares linear regression. This provides the conversion factors required to convert the measured signal at the lock-in amplifier to the respective glucose concentrations. This was followed by validation experiments, which were repeated four times on a moving birefringent sample cuvette. The glucose concentration was varied from 0to600mgdl in 50-mgdl steps. Simple linear regression was applied to data points for individual wavelengths. Figures 2 and 3 show predicted glucose concentration as a function of actual glucose concentration. It is evident that a single wavelength open-loop system ( 635nm or 830nm ) is incapable of predicting glucose concentration in a test cell with time-variant birefringence. For instance, the mean error in prediction of glucose was calculated to be 186.9mgdl and 185.6mgdl , with mean coefficient of determination (R2) values of 0.149 and 0.166, respectively. This calculated value of error in glucose estimation is an average of errors in glucose estimation for four individual sets. It does not take into account the effect of using a single calibration model to validate separate data sets, the consequence of which can be seen as the extent of error bars in Figs. 2 and 3, which are an order of magnitude larger than the mean error in glucose estimation. This variation between data sets and thereby the lack of repeatability is a result of the open-loop nature of the system, which makes it impractical to use a single calibration model for validation. Hence, these error bars signify the error due both to time-variant birefringence and to the lack of reproducibility from other noise disturbances. To see the effect of utilizing dual wavelengths, the combined dual wavelength open-loop data was used in a multiple-linear regression analysis. The mean error in prediction of glucose was calculated to be slightly less at 181.8mgdl with mean coefficient of determination (R2) of 0.516. As shown in Fig. 4 , the magnitude of error bars is also visibly less, but the open-loop system, as expected, is still incapable of predicting glucose concentrations at physiologic ranges.

Fig. 2

Mean estimated glucose concentration as a function of actual glucose concentration for an open-loop single-wavelength model using the 635-nm wavelength. Error bars represent variation between four separate experiments and are quite high as anticipated for this system in the presence of variable birefringence and other noise disturbances not compensated in an open-loop system.


Fig. 3

Mean estimated glucose concentration as a function of actual glucose concentration for an open-loop single-wavelength model using the 830-nm wavelength. Error bars represent variation between four separate experiments and are quite high as anticipated for this system in the presence of variable birefringence and other noise disturbances not compensated in an open-loop system.


Fig. 4

Mean predicted glucose concentrations for the real-time, open-loop dual-wavelength system using a multiregression model. Error bars represent variation between four separate runs of experiments. Note that the open-loop dual-wavelength system significantly reduced the magnitude of the error bars compared to single-wavelength system, but they are still much too high for physiologic monitoring due to other noise disturbances not compensated by the open-loop system.


The system was then calibrated for closed-loop operation followed by validation experiments. The feedback loops for both wavelengths were closed in real-time simultaneously using two separate PID controllers. The data acquisition time was set to be 500ms , which was just over the time taken by the control mechanism to stabilize the system. Figures 5 and 6 show the predicted glucose concentration as a function of actual glucose concentration for the closed-loop case. It is apparent that the variation between different data sets is reduced, since the scale of error bars is an order of magnitude less when compared to the open-loop single-wavelength system (Figs. 2 and 3). Still, this is not enough to accurately determine glucose concentrations in the sample: the mean error in prediction of glucose was calculated to be 164.6mgdl and 131.6mgdl , with mean coefficient of determination (R2) values of 0.566 and 0.355 for 635-nm and 830-nm wavelengths, respectively. This result demonstrates the problem, albeit more severe in the moving test cell than what we are likely to encounter in vivo, since the change in the birefringence of the sample cloaks the optical rotation due to glucose. To nullify the effect of this birefringence, the combined real-time, dual-wavelength data is again used in a multiple-linear regression analysis. As shown in Fig. 7 , this analysis significantly increased the overall linearity of the collected data (mean R2 -value of 0.996) and reduced the mean error in prediction of glucose to 12.8mgdl . The application of multiple-linear regression is analogous to scaled subtraction. The general idea is to use this regression analysis to predict the contribution of birefringence to the total rotation of state of polarization. The data points for both wavelengths are used to calculate optimal weights for respective data sets. Once these coefficients are determined, the sample noise can be removed by subtracting the scaled data sets. The overall result is reduction in the effect of time-varying birefringence due to motion artifact, which manifests as common-mode noise for both wavelengths.

Fig. 5

Mean estimated glucose concentration as a function of actual glucose concentration for a closed-loop single-wavelength model using the 635-nm wavelength. Error bars represent variation between four separate experiments. Note that the closed-loop single-wavelength system cannot accommodate for the time-varying birefringence.


Fig. 6

Mean estimated glucose concentration as a function of actual glucose concentration for a closed-loop single-wavelength model using the 830-nm wavelength. Error bars represent variation between four separate experiments. Note that the closed-loop single-wavelength system cannot accommodate for the time-varying birefringence.


Fig. 7

Mean predicted glucose concentrations for the real-time, closed-loop dual-wavelength system using a multiregression model. Error bars represent variation between four separate runs of experiments. Note that the dual-wavelength real-time PID closed-loop system can be used to accommodate time-varying birefringence.


These results clearly demonstrate the advantages of using a closed-loop system over an open-loop system and the dual-wavelength system compared to the single-wavelength system for the case of varying birefringence. By the way of theory, closed-loop systems are much more efficient in rejecting disturbances.32 They are also less sensitive to random fluctuations in operating conditions, which makes them less susceptible to noise. Previously reported optical polarimetric techniques have utilized feedback based on scan-based algorithms,28, 31 which have inherently slow dynamic response for zero steady-state error. Our proposed approach utilizes real-time, dual-wavelength feedback using PID control. The use of real-time feedback is essential, since the ultimate application of this technique is to minimize the effect of time-variant corneal birefringence in the eye. In a previous study from our group,33 the primary motion-induced corneal birefringence artifact in a rabbit model was found to be mainly due to respiratory motion (1.5Hz) . Our feedback control mechanism took less than 300ms to stabilize the system, which should be adequately fast to minimize the respiratory motion artifact. Another possible way to eliminate the effect of polarization rotation due to birefringence that was proposed recently employed a dedicated birefringence compensation device.27 Although effective, the inclusion of an extra digital interface to control the variable retarder requires an additional control loop, within the Faraday feedback loop, which may increase the time taken to null the system. Also, the advantage of using a PID control is that the feedback system can be easily hard-wired, e.g., by implementing PID control on a field-programmable gate array (FPGA) device for a hard-wired system. Using a FPGA device can enable us to circumvent the inherent lag associated with software delays and control of computer-programmable devices in the personal computing environment



In summary, we have presented a real-time optical polarimetric approach for glucose sensing utilizing two wavelengths. The use of a second wavelength along with real-time feedback enabled the reduction of the effect of time-variant birefringence. This significantly enhanced the sensitivity of the system in the presence of motion artifact, thereby reducing the error in glucose estimation by an order of a magnitude compared to a single-wavelength model and compared to the open-loop dual-wavelength model. The next step in this investigation is to develop an efficient eye coupling mechanism and to modify the current system for in vivo experiments on rabbits’ eyes. We will also explore more sophisticated PID control algorithms. Although the current PID controller performance is adequate, development of a more complex control system may provide us with better transient and steady-state characteristics of the system.


This work was supported by a grant from National Institutes of Health (R01 DK076772). The authors would like to thank Tony Akl, PhD student in the Optical Biosensing Laboratory, for his technical assistance and helpful discussions.


1.  T. D. Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” N. Engl. J. Med.0028-4793 329(14), 977–986 (1993). 10.1056/NEJM199309303291401 Google Scholar

2.  R. O. Esenaliev, K. V. Larin, I. V. Larina, and M. Motamedi, “Noninvasive monitoring of glucose concentration with optical coherence tomography,” Opt. Lett.0146-9592 26(13), 992–994 (2001). 10.1364/OL.26.000992 Google Scholar

3.  V. V. Sapozhnikova, R. V. Kuranov, I. Cicenaite, R. O. Esenaliev, and D. S. Prough, “Effect on blood glucose monitoring of skin pressure exerted by an optical coherence tomography probe,” J. Biomed. Opt.1083-3668 13(2), 021112 (2008). 10.1117/1.2909671 Google Scholar

4.  V. V. Sapozhnikova, D. Prough, R. V. Kuranov, I. Cicenaite, and R. O. Esenaliev, “Influence of osmolytes on in vivo glucose monitoring using optical coherence tomography,” Exp. Biol. Med.0071-3384 231(8), 1323–1332 (2006). Google Scholar

5.  B. Rabinovitch, W. F. March, and R. L. Adams, “Noninvasive glucose monitoring of the aqueous humor of the eye: Part I. Measurement of very small optical rotations,” Diabetes Care0149-5992 5(3), 254–258 (1982). 10.2337/diacare.5.3.254 Google Scholar

6.  W. F. March, B. Rabinovitch, and R. L. Adams, “Noninvasive glucose monitoring of the aqueous humor of the eye: II. Animal studies and the scleral lens,” Diabetes Care0149-5992 5(3), 259–265 (1982). 10.2337/diacare.5.3.259 Google Scholar

7.  G. L. Coté, M. D. Fox, and R. B. Northrop, “Noninvasive optical polarimetric glucose sensing using a true phase measurement technique,” IEEE Trans. Biomed. Eng.0018-9294 39(7), 752–756 (1992). 10.1109/10.142650 Google Scholar

8.  M. J. Goetz Jr., M. D. Fox, and R. B. Northrop, “Microdegree polarimetry using a diode laser for glucose detection,” in Proc. 18th IEEE Annual Northeast Bioengineering Conf., pp. 97–98, IEEE, New York (1992). Google Scholar

9.  T. W. King, G. L. Coté, R. McNichols, and M. J. Goetz Jr., “Multispectral polarimetric glucose detection using a single Pockels cell,” Opt. Eng.0091-3286 33(8), 2746–2753 (1994). 10.1117/12.173556 Google Scholar

10.  B. D. Cameron and G. L. Coté, “Noninvasive glucose sensing utilizing a digital closed-loop polarimetric approach,” IEEE Trans. Biomed. Eng.0018-9294 44(12), 1221–1227 (1997). 10.1109/10.649993 Google Scholar

11.  C. Chou, C. Y. Han, W. C. Kuo, Y. C. Huang, C. M. Feng, and J. C. Shyu, “Noninvasive glucose monitoring in vivo with an optical heterodyne polarimeter,” Appl. Opt.0003-6935 37(16), 3553–3557 (1998). 10.1364/AO.37.003553 Google Scholar

12.  B. D. Cameron, H. W. Gorde, B. Satheesan, and G. L. Coté, “The use of polarized laser light through the eye for noninvasive glucose monitoring,” Diabetes Technol. Ther.1520-9156 1(2), 135–143 (1999). 10.1089/152091599317341 Google Scholar

13.  J. L. Lambert, J. M. Morookian, S. J. Sirk, and M. S. Borchert, “Measurement of aqueous glucose in a model anterior chamber using Raman spectroscopy,” J. Raman Spectrosc.0377-0486 33(7), 524–529 (2002). 10.1002/jrs.871 Google Scholar

14.  A. M. Enejder, T. G. Scecina, J. Oh, M. Hunter, W. C. Shih, S. Sasic, G. L. Horowitz, and M. S. Feld, “Raman spectroscopy for noninvasive glucose measurements,” J. Biomed. Opt.1083-3668 10(3), 031114 (2005). 10.1117/1.1920212 Google Scholar

15.  Y. C. Shen, A. G. Davies, E. H. Linfield, T. S. Elsey, P. F. Taday, and D. D. Arnone, “The use of Fourier-transform infrared spectroscopy for the quantitative determination of glucose concentration in whole blood,” Phys. Med. Biol.0031-9155 48(13), 2023–2032 (2003). 10.1088/0031-9155/48/13/313 Google Scholar

16.  L. A. Nelson, J. C. McCann, A. W. Loepke, J. Wu, B. B. Dor, and C. D. Kurth, “Development and validation of a multiwavelength spatial domain near-infrared oximeter to detect cerebral hypoxia-ischemia,” J. Biomed. Opt.1083-3668 11(6), 064022 (2006). 10.1117/1.2393251 Google Scholar

17.  J. J. Burmeister, M. A. Arnold, and G. W. Small, “Noninvasive blood glucose measurements by near-infrared transmission spectroscopy across human tongues,” Diabetes Technol. Ther.1520-9156 2(1), 5–16 (2000). 10.1089/152091500316683 Google Scholar

18.  R. M. Rounds, B. L. Ibey, H. T. Beier, M. V. Pishko, and G. L. Coté, “Microporated PEG spheres for fluorescent analyte detection,” J. Fluoresc.1053-0509 17(1), 57–63 (2007). 10.1007/s10895-006-0143-3 Google Scholar

19.  R. J. Russell, M. V. Pishko, C. C. Gefrides, M. J. McShane, and G. L. Coté, “A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel,” Anal. Chem.0003-2700 71(15), 3126–3132 (1999). 10.1021/ac990060r Google Scholar

20.  J. F. Sierra, J. Galban, S. De Marcos, and J. R. Castillo, “Direct determination of glucose in serum by fluorimetry using a labeled enzyme,” Anal. Chim. Acta0003-2670 414(1–2), 33–41 (2000). 10.1016/S0003-2670(00)00831-X Google Scholar

21.  F. Hussain, D. J. S. Birch, and J. C. Pickup, “Glucose sensing based on the intrinsic fluorescence of sol-gel immobilized yeast hexokinase,” Anal. Biochem.0003-2697 339(1), 137–143 (2005). 10.1016/j.ab.2005.01.016 Google Scholar

22.  K. C. Hadley and I. A. Vitkin, “Optical rotation and linear and circular depolarization rates in diffusively scattered light from chiral, racemic, and achiral turbid media,” J. Biomed. Opt.1083-3668 7(3), 291–299 (2002). 10.1117/1.1483880 Google Scholar

23.  B. D. Cameron, J. S. Baba, and G. L. Coté, “Measurement of the glucose transport time delay between the blood and aqueous humor of the eye for the eventual development of a noninvasive glucose sensor,” Diabetes Technol. Ther.1520-9156 3(2), 201–207 (2001). 10.1089/152091501300209552 Google Scholar

24.  G. L. Coté, H. Gorde, J. Janda, and B. D. Cameron, “Multispectral polarimetric system for glucose monitoring,” in Biomedical Sensing and Imaging Technologies, R. A. Lieberman and T. Vo-Dinh, Eds., Proc. SPIE0277-786X 3253, 36–40 (1998). 10.1117/12.308047 Google Scholar

25.  R. R. Ansari, S. Bockle, and L. Rovati, “New optical scheme for a polarimetric-based glucose sensor,” J. Biomed. Opt.1083-3668 9(1), 103–115 (2004). 10.1117/1.1626664 Google Scholar

26.  R. Rawer, W. Stork, and C. F. Kreiner, “Non-invasive polarimetric measurement of glucose concentration in the anterior chamber of the eye,” Graefe's Arch. Clin. Exp. Ophthalmol.0721-832X 242(12), 1017–1023 (2004). 10.1007/s00417-004-1031-7 Google Scholar

27.  B. D. Cameron and H. Anumula, “Development of a real-time corneal birefringence compensated glucose sensing polarimeter,” Diabetes Technol. Ther.1520-9156 8(2), 156–164 (2006). 10.1089/dia.2006.8.156 Google Scholar

28.  Q. Wan, G. L. Coté, and J. B. Dixon, “Dual-wavelength polarimetry for monitoring glucose in the presence of varying birefringence,” J. Biomed. Opt.1083-3668 10(2), 024029 (2005). 10.1117/1.1891175 Google Scholar

29.  J. S. Baba, J.-R. Chung, and G. L. Coté, “Laser polarization noise elimination in sensitive polarimetric systems,” Opt. Eng.0091-3286 41(5), 938–942 (2002). 10.1117/1.1464869 Google Scholar

30.  M. J. Goetz Jr., “Microdegree polarimetry for glucose detection,” M.S. Thesis, University of Connecticut, Storrs, CT (1992). Google Scholar

31.  B. H. Malik and G. L. Coté, “Real-time dual wavelength polarimetry for glucose sensing,” in Optical Diagnostics and Sensing IX, G. L. Coté, Ed., Proc. SPIE0277-786X 7186, 718604 (2009). 10.1117/12.809681 Google Scholar

32.  G. F. Franklin, D. J. Powell, and A. Emami-Naeini, Feedback Control of Dynamic Systems, Prentice Hall PTR, Upper Saddle River, NJ (2001). Google Scholar

33.  J. S. Baba, B. D. Cameron, S. Theru, and G. L. Coté, “Effect of temperature, pH, and corneal birefringence on polarimetric glucose monitoring in the eye,” J. Biomed. Opt.1083-3668 7(3), 321–328 (2002). 10.1117/1.1484163 Google Scholar

Bilal H. Malik, Gerard L. Coté, "Real-time, closed-loop dual-wavelength optical polarimetry for glucose monitoring," Journal of Biomedical Optics 15(1), 017002 (1 January 2010). https://doi.org/10.1117/1.3290819




Control systems


Signal detection

Active optics

Back to Top